series-c-plus
Stage
1
Investors
About
Soley Therapeutics is a biotechnology company that combines artificial intelligence and proprietary cell imaging to discover and develop first-in-class medicines by analyzing whole-cell responses under stress conditions.
Explore Soley Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.